Oncology ASCO 2024 - Mohit Manrao Just about everyone seems to agree that the runaway success story of ASCO this year is AstraZeneca, with plenary sessions for the sixth year in a row and
R&D What’s next for oncology research? Eliminating cancer as a cause of death is a highly ambitious goal, but oncology researchers are showing no signs of giving up the fight in 2023.
News Most pharmas not ready for AI in customer engagement Pharma wants to use AI for digital engagement with healthcare professionals and patients, but most feel unprepared to forge ahead, says survey.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
